{
  "type": "hyp",
  "text": "The bone marrow-derived endothelial cell line SKW6.4 a prototype for mitochondria-independent death receptor-induced apoptosis was also sensitized to anti-CD95 and vascular endothelial growth factor (VEGF)-mediated apoptosis.\n",
  "self": {
    "NER": {
      "answers": [
        "anti-CD95"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the prototype for mitochondria-independent death receptor-induced apoptosis"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "The bone marrow-derived endothelial cell line",
        "SKW6.4 a prototype",
        "mitochondria-independent death receptor-induced apoptosis",
        "anti-CD95 and vascular endothelial growth factor",
        "VEGF)-mediated apoptosis"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was the prototype for mitochondria-independent death receptor-induced apoptosis",
          "What was the cell line that was sensitized to anti-CD95 and VEGF",
          "What is the SKW6.4 a prototype for?",
          "What was the SKW6.4 cell line sensitized to?",
          "What was the SKW6.4 cell line sensitized to?"
        ]
      }
    }
  },
  "asked": {
    "What parameters were compared between 4- and 16-week groups?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0006093978881835938,
        "ground_truth": {
          "Histologic": {
            "bertscore": 0.6898713707923889,
            "f1": 0
          }
        }
      }
    },
    "What is the primary and secondary bone vascularization?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0032102465629577637,
        "ground_truth": {
          "trabecula neovascularization": {
            "bertscore": 0.6619634628295898,
            "f1": 0
          }
        }
      }
    },
    "What was the length of the study?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0001780390739440918,
        "ground_truth": {
          "16-week": {
            "bertscore": 0.6910080909729004,
            "f1": 0
          }
        }
      }
    },
    "What was compared between 4- and 16-week groups?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0001946091651916504,
        "ground_truth": {
          "Histologic parameters": {
            "bertscore": 0.677298903465271,
            "f1": 0
          }
        }
      }
    },
    "What are the two histologic parameters?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.09218347072601318,
        "ground_truth": {
          "primary and secondary bone trabecula neovascularization": {
            "bertscore": 0.6497385501861572,
            "f1": 0
          }
        }
      }
    },
    "What is the main component of the vascularization of the trabecula?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005829036235809326,
        "ground_truth": {
          "bone marrow": {
            "bertscore": 0.6805211901664734,
            "f1": 0
          }
        }
      }
    },
    "What is the most important histologic parameter?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0002765059471130371,
        "ground_truth": {
          "connective tissue formation": {
            "bertscore": 0.6707776784896851,
            "f1": 0
          }
        }
      }
    },
    "What groups were compared for histologic parameters?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0013905763626098633,
        "ground_truth": {
          "4- and 16-week groups": {
            "bertscore": 0.5957083106040955,
            "f1": 0
          }
        }
      }
    }
  }
}